Could an MUC1-Targeted Vaccine Benefit Colorectal Cancer Patients With Liver Mets?

Researchers tested an antigen-specific cancer vaccine known as tecemotide vs placebo in patients with colorectal cancer and liver metastases to see if outcomes would be improved.

Source: CancerNetwork - January 22, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news